Clinical Trials Directory

Trials / Unknown

UnknownNCT00938418

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Phase II Study on Dose Escalated, Accelerated Hypofractionated Intensity Modulated Radiotherapy for Stage III Non-Small Cell Lung Cancer With Concurrent Chemotherapy

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
43 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Locally advanced non-small cell lung cancer can be treated successfully with chemotherapy and radiation. However, the cure rate is low. This study is carried out to find out whether giving radiotherapy at a higher dose over fewer treatment sessions with intensity modulated radiotherapy (IMRT) can improve the treatment outcome. This study aims to recruit 43 patients from National University Hospital and Tan Tock Seng Hospital over a period of about 2 years.

Conditions

Interventions

TypeNameDescription
RADIATIONDose escalated, accelerated, hypofractionated radiotherapyIntensity modulated radiotherapy with concurrent chemotherapy

Timeline

Start date
2009-07-01
Primary completion
2011-07-01
First posted
2009-07-13
Last updated
2009-07-13

Locations

3 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT00938418. Inclusion in this directory is not an endorsement.

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer (NCT00938418) · Clinical Trials Directory